Jeffrey A. Meyerhardt

Active 1990–2026

Also published as
Jeffrey A Meyerhardt
293
Papers
48,340
Citations
118
h-index
277
i10-index

Citations

Citations per year for Jeffrey A. Meyerhardt1990: 1 citations1991: 4 citations1993: 2 citations1994: 3 citations1995: 2 citations1996: 2 citations1997: 4 citations1998: 1 citations1999: 3 citations2000: 6 citations2001: 4 citations2002: 8 citations2003: 7 citations2004: 17 citations2005: 46 citations2006: 61 citations2007: 69 citations2008: 145 citations2009: 193 citations2010: 282 citations2011: 268 citations2012: 295 citations2013: 373 citations2014: 403 citations2015: 402 citations2016: 369 citations2017: 414 citations2018: 502 citations2019: 1,626 citations2020: 1,812 citations2021: 1,927 citations2022: 1,622 citations2023: 1,350 citations2024: 2,330 citations2025: 1,244 citations2026: 36 citations1992: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,591 citing papers, 24.4% of this breakdownChina: 2,826 citing papers, 15% of this breakdownItaly: 1,007 citing papers, 5.4% of this breakdownUnited Kingdom: 993 citing papers, 5.3% of this breakdownGermany: 811 citing papers, 4.3% of this breakdownCanada: 724 citing papers, 3.8% of this breakdownJapan: 681 citing papers, 3.6% of this breakdownAustralia: 614 citing papers, 3.3% of this breakdownFrance: 611 citing papers, 3.2% of this breakdownSpain: 556 citing papers, 3% of this breakdownNetherlands: 507 citing papers, 2.7% of this breakdownSouth Korea: 431 citing papers, 2.3% of this breakdown
0%24.4%Other 23.7%

Fields

  • Medicine70.3%
  • Biochemistry, Genetics and Molecular Biology21.6%
  • Immunology and Microbiology2.2%
  • Computer Science0.8%
  • Neuroscience0.7%
  • Nursing0.6%
  • Other3.8%

Topics

  • Colorectal Cancer Treatments and Studies4.8%
  • Colorectal Cancer Surgical Treatments3.9%
  • Genetic factors in colorectal cancer3.7%
  • Cancer survivorship and care3%
  • Cancer Immunotherapy and Biomarkers3%
  • Colorectal Cancer Screening and Detection2.9%
  • Other78.7%

Coauthors

All papers

Open in search
  1. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charles Schneider, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Kristina M. Gregory, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2021 cited by 1,748

  2. Fusobacterium nucleatumin colorectal carcinoma tissue and patient prognosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2015 cited by 1,074

  3. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leonard B. Saltz, Charles Schneider, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Eden Stotsky‐Himelfarb, Anna Tavakkoli, Christopher G. Willett, Kristina M. Gregory, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2022 cited by 819

  4. American Cancer Society nutrition and physical activity guideline for cancer survivors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2022 cited by 722

  5. Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 617

  6. Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William B. Bradford, Edmond Wong, Alexa Michel, Isobel J. Fetter, Giulia Siravegna, A. Gemma, Arlene H. Sharpe, Shadmehr Demehri, Rebecca Leary, Catarina D. Campbell, Ömer Yılmaz, Gad Getz, Aparna R. Parikh, Nir Hacohen, Ryan B. Corcoran - Nature Medicine 2023 cited by 187

  7. Preoperative Treatment of Locally Advanced Rectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 448

  8. Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 1,126

  9. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2016 cited by 930

  10. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - JAMA 2017 cited by 893

  11. Histopathology images predict multi-omics aberrations and prognoses in colorectal cancer patients

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 125

  12. Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 331

  13. Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas

    Authors: , , , , , , , , , , , , , , , , , - JAMA Oncology 2022 cited by 281

  14. Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Giannakis, Shuji Ogino - Cancer Immunology Research 2018 cited by 226

  15. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Lisa Gurski, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2018 cited by 994

  16. The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Immunology Research 2020 cited by 236

  17. NCCN Guidelines Insights: Colon Cancer, Version 2.2018

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2018 cited by 1,029

  18. Nutrition and physical activity guidelines for cancer survivors

    Authors: , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2012 cited by 2,024

  19. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, Benjamin D. Shogan, John M. Skibber, Constantinos T. Sofocleous, Anna Tavakkoli, Christopher G. Willett, Christina Wu, Lisa A. Gurski, Jenna Snedeker, Frankie Jones - Journal of the National Comprehensive Cancer Network 2024 cited by 308

  20. Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women

    Authors: , , , , , , , , , , , - Gut 2021 cited by 237

  21. Western-Style Diet, pks Island-Carrying Escherichia coli, and Colorectal Cancer: Analyses From Two Large Prospective Cohort Studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Giannakis, Shuji Ogino - Gastroenterology 2022 cited by 109

  22. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 cited by 298

  23. Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Leggett, Vicki Whitehall, Neal I. Walker, Ian Brown, Mark Bettington, Reiko Nishihara, Charles S. Fuchs, Jochen K. Lennerz, Marios Giannakis, Jonathan A. Nowak, Shuji Ogino - Clinical Cancer Research 2021 cited by 94

  24. Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma

    Authors: , , , , , , , , , , , , , , , - The Oncologist 2014 cited by 372